Kelly McMasters
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma (NCT04513028) | Kelly McMasters | 2020-11-03 |
Track Kelly McMasters automatically
Every clearance here is in the API, with alerts when new ones post.